• search hit 7 of 10
Back to Result List

Second-line bosutinib is effective and feasible in patients failing second generation TKI (2G-TKI) in chronic phase Chronic Myeloid Leukemia (CML) - an analysis of a subcohort of the Bodo trial (CML-VII-study of the German CML Study Group) [Abstract]

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Susanne Isfort, Kirsi Manz, Lino L. Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R. Goethert, Thomas Illmer, Philippe Schafhausen, Haifa Kathrin Al-Ali, Frank Stegelmann, Mathias Hänel, Tim Pfeiffer, Aristoteles Giagounidis, Georg-Nikolaus Franke, Steffen Koschmieder, Alice Fabarius, Thomas Ernst, Mareille Warnken-Uhlich, Denise Kohn, Markus Pfirrmann, Dominik Wolf, Tim H. H. Brummendorf
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/117415
ISSN:0006-4971OPAC
ISSN:1528-0020OPAC
Parent Title (English):Blood
Publisher:American Society of Hematology
Place of publication:Washington, DC
Type:Article
Language:English
Year of first Publication:2024
Publishing Institution:Universität Augsburg
Release Date:2024/12/10
Volume:144
Issue:Supplement 1
First Page:1766
DOI:https://doi.org/10.1182/blood-2024-208687
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Innere Medizin mit Schwerpunkt Hämatologie und Onkologie